SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Richtech Robotics, Inc. engages in the development of robotics and artificial intelligence. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics Inc. (RR) is currently trending following news of its collaboration with Microsoft's AI Co-Innovation Labs to integrate advanced agentic AI into its ADAM robots. This partnership has ignited significant community discussion, with many investors anticipating substantial future growth and a bolstered position within the rapidly evolving robotics and AI sector. While excitement is high regarding the potential for enhanced real-world robotic systems, some market participants are also considering the near-term implications.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending intensely as strong performance from memory sector peers, combined with an accelerating AI-driven demand, fuels expectations of a prolonged memory supercycle. The community is sharply divided between bulls anticipating significant further rallies amid supply shortages, and bears warning of an unsustainable bubble and potential crash after upcoming earnings, driving extreme volatility.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical (DRTS) is trending with significant community excitement surrounding a pending PMDA approval in Japan, complementing recent positive clinical data from its Alpha DaRT technology across various solid tumors. Investors are actively discussing the revolutionary potential of this oncology platform, further fueled by growing institutional interest and notable increases in trading volume.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares (GLD) is trending as gold futures reach historical highs, fueling intense community discussion around relentless buying pressure and a potential short squeeze. Investors are pouring into GLD, driven by FOMO and its perceived role as a critical safe-haven asset amid concerns over dollar weakness and geopolitical uncertainty. This parabolic move is also sparking debate about a rotation from crypto to traditional precious metals.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune is currently trending following a recent $75 million direct offering to a fundamental institutional investor, intended to fully fund its Phase 3 MASH trial preparation. This capital raise, coupled with Barclays initiating coverage with an 'Overweight' rating and a $20 price target, has fueled intense community discussion. Many are debating whether this strategic financing de-risks the company for a potential acquisition or partnership, leveraging its Breakthrough Therapy Designation for pemvidutide in the competitive MASH and weight loss market, despite some short-term concerns about dilution.

Nokia Oyj engages in the provision of network infrastructure, technology, and software services. It operates through the following segments: Mobile Networks, Network Infrastructure, Cloud and Network Services, and Nokia Technologies. The Mobile Networks segment offers technologies for Radio Access Networks (RAN) as well as Microwave Radio Links (MWR) for transport networks. The Network Infrastructure serves communication service providers, enterprises, webscales and public sector customers. The Cloud and Network Services segment builds around software and the cloud and is focused on driving leadership in cloud-native software and as-a-service delivery models, as demand for critical networks accelerates; and with strong market positions in communications software, private wireless networks, and cognitive (or intelligent) services. The Nokia Technologies segment, building on decades of innovation and R&D leadership in technologies used in virtually all mobile devices used today, is expanding the Nokia patent licensing business, reintroducing the Nokia brand to smartphones through brand licensing, and establishing a technology licensing business. The company was founded by Fredrik Idestam in 1865 and is headquartered in Espoo, Finland.

Nokia Corp - ADR

Nokia Corp

Nokia is trending as it rapidly advances its strategic pivot towards AI-native network infrastructure, underscored by a significant partnership with NVIDIA on AI-RAN development and substantial investments in US AI-ready network R&D. The community is actively discussing its transformation from a legacy company to a crucial enabler of 5G, 6G, and edge AI, viewing it as an underappreciated deep value play poised for future growth despite market volatility.

Stride, Inc. is a technology-based educational company, which engages in the provision of proprietary and third-party curriculum, software systems and educational services. It also offers online curriculum and career services to middle and high school students, under the Destinations Career Academy brand name. The company was founded by Ronald J. Packard in 2000 and is headquartered in Reston, VA.

Stride Inc

Stride Inc. is trending following its robust recent earnings and surging enrollment growth, especially in career learning, prompting widespread community discussion about its significant undervaluation. This sentiment is amplified by the company's authorization of a substantial stock repurchase program and speculation about a potential short squeeze. Investors are actively discussing the strong prospects for a substantial upward re-rating.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ai is generating significant buzz following reports of a potential merger with Automation Anywhere and recent key contracts with the U.S. Army and Department of Health and Human Services (HHS). This news is fueling intense debate among investors, with many anticipating a potential short squeeze given the substantial short interest, while others remain skeptical about the company's long-term profitability and valuation in the rapidly evolving AI landscape.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with knife ($CAW) is trending with its highly engaged community touting it as 'the only option' and highlighting its multichain expansion across platforms like Solana, Cronos, and Base. Discussions are buzzing around its deflationary burn mechanism and anticipated future developments, fueling bullish sentiment among its supporters.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing strong momentum, driven by the persistent "memory supercycle" and soaring AI-driven demand for high-bandwidth memory, further amplified by strategic market developments including a significant Singapore investment and potential tariffs on competitors. The community is exceptionally bullish, frequently highlighting its relatively low forward P/E and anticipating a significant re-rating as the market recognizes its critical role in the evolving AI infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AVEO is a late-stage biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. AVEO's proprietary, integrated cancer biology platform enables the company to pursue highly efficient drug development strategies in oncology that increase the probability of clinical success and provides a discovery engine for high-value targets and therapies. This approach has resulted in a balanced pipeline of novel cancer therapies focused on well-validated targets (VEGFR, EGFR) and promising novel targets (HGF, FGFR, ErbB3 and NOTCH), as well as collaborations with Eli Lilly, Merck, OSI Pharmaceuticals, Schering-Plough, and Biogen Idec. The company was established in 2001 and is based in Cambridge, Massachusetts.

AVEO
AVEO Pharmaceuticals Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AVEO News

AVEOAVEO Pharmaceuticals Inc